Company / EPS (Diluted)
OptimizeRx Corp EPS (Diluted) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.10
FY2025
5-year range
-$1.10 / $0.02
FY2021-FY2025
Trend
-6.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has declined for 3 consecutive years, from $0.02 in FY2022 to $-1.10 in FY2025.
Based on SEC 10-K filings.
-1.10 in FY2025.
Declined from $-0.64 to $-1.10 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- OptimizeRx Corp's eps (diluted) has declined for 3 consecutive years.
- In FY2025, eps (diluted) decreased 6.8% year-over-year.
- Peak eps (diluted) was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.10 | -6.8% |
| FY2024 | -$1.03 | -60.9% |
| FY2023 | -$0.64 | -3300.0% |
| FY2022 | $0.02 | +113.3% |
| FY2021 | -$0.15 | +34.8% |
| FY2020 | -$0.23 | -1250.0% |
| FY2019 | $0.02 | +109.5% |
| FY2018 | -$0.21 | -320.0% |
| FY2017 | -$0.05 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026